AGLE Annual Total Liabilities
$20.84 M
-$5.15 M-19.80%
31 December 2022
Summary:
As of January 26, 2025, AGLE annual total liabilities is $20.84 million, with the most recent change of -$5.15 million (-19.80%) on December 31, 2022. During the last 3 years, it has fallen by -$2.26 million (-9.80%).AGLE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGLE Quarterly Total Liabilities
$452.67 M
+$1.77 M+0.39%
30 September 2023
Summary:
As of January 26, 2025, AGLE quarterly total liabilities is $452.67 million, with the most recent change of +$1.77 million (+0.39%) on September 30, 2023. Over the past year, it has increased by +$428.66 million (+1785.25%).AGLE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGLE Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -19.8% | +1785.3% |
3 y3 years | -9.8% | +2238.5% |
5 y5 years | +263.1% | +5859.3% |
AGLE Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -19.8% | at high |
Aeglea BioTherapeutics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2023 | - | $452.67 M(+0.4%) |
June 2023 | - | $450.90 M(+2298.3%) |
Mar 2023 | - | $18.80 M(-9.8%) |
Dec 2022 | $20.84 M(-19.8%) | $20.84 M(-13.2%) |
Sept 2022 | - | $24.01 M(+6.5%) |
June 2022 | - | $22.55 M(+4.8%) |
Mar 2022 | - | $21.51 M(-17.2%) |
Dec 2021 | $25.98 M(+19.3%) | $25.98 M(-3.7%) |
Sept 2021 | - | $26.98 M(-3.5%) |
June 2021 | - | $27.96 M(-29.9%) |
Mar 2021 | - | $39.86 M(+83.0%) |
Dec 2020 | $21.79 M(-5.7%) | $21.79 M(+12.5%) |
Sept 2020 | - | $19.36 M(-6.3%) |
June 2020 | - | $20.65 M(-6.0%) |
Mar 2020 | - | $21.98 M(-4.9%) |
Dec 2019 | $23.10 M | $23.10 M(+13.8%) |
Sept 2019 | - | $20.30 M(+13.5%) |
June 2019 | - | $17.88 M(+46.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $12.23 M(+18.6%) |
Dec 2018 | $10.31 M(+79.6%) | $10.31 M(+35.7%) |
Sept 2018 | - | $7.60 M(+21.2%) |
June 2018 | - | $6.27 M(+6.8%) |
Mar 2018 | - | $5.87 M(+2.2%) |
Dec 2017 | $5.74 M(+40.1%) | $5.74 M(+14.9%) |
Sept 2017 | - | $4.99 M(+10.0%) |
June 2017 | - | $4.54 M(+11.2%) |
Mar 2017 | - | $4.08 M(-0.3%) |
Dec 2016 | $4.10 M(+60.7%) | $4.10 M(+6.1%) |
Sept 2016 | - | $3.86 M(+14.4%) |
June 2016 | - | $3.38 M(-12.1%) |
Mar 2016 | - | $3.84 M(+50.7%) |
Dec 2015 | $2.55 M(+141.0%) | $2.55 M(+4.0%) |
Sept 2015 | - | $2.45 M(-10.5%) |
June 2015 | - | $2.74 M(+122.6%) |
Mar 2015 | - | $1.23 M(+16.3%) |
Dec 2014 | $1.06 M(-25.1%) | $1.06 M |
Dec 2013 | $1.41 M | - |
FAQ
- What is Aeglea BioTherapeutics annual total liabilities?
- What is the all time high annual total liabilities for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics annual total liabilities year-on-year change?
- What is Aeglea BioTherapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics quarterly total liabilities year-on-year change?
What is Aeglea BioTherapeutics annual total liabilities?
The current annual total liabilities of AGLE is $20.84 M
What is the all time high annual total liabilities for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high annual total liabilities is $25.98 M
What is Aeglea BioTherapeutics annual total liabilities year-on-year change?
Over the past year, AGLE annual total liabilities has changed by -$5.15 M (-19.80%)
What is Aeglea BioTherapeutics quarterly total liabilities?
The current quarterly total liabilities of AGLE is $452.67 M
What is the all time high quarterly total liabilities for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high quarterly total liabilities is $452.67 M
What is Aeglea BioTherapeutics quarterly total liabilities year-on-year change?
Over the past year, AGLE quarterly total liabilities has changed by +$428.66 M (+1785.25%)